Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

被引：0
|
作者：
Agersborg, Sally [1 ]
Mixon, Christopher [1 ]
Thanh Nguyen [1 ]
Aithal, Sramila [2 ]
Blocker, Forrest [1 ]
Weiss, Lawrence [1 ]
Gasparini, Robert [1 ]
Jiang, Shiping [1 ]
Chen, Wayne [1 ]
Hess, Gregory [3 ]
Albitar, Maher [1 ]
机构：
[1] NeoGenomics Inc, Aliso Viejo, CA USA
[2] Canc Treatment Ctr Amer, Philadelphia, PA USA
[3] Symphony Hlth, Conshohocken, PA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4524
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Her2 FISH amplification in ER/PR/Her2 IHC negative breast cancer
    Sahoo, Sunati
    Hwang, Helena
    CANCER RESEARCH, 2015, 75
  • [22] Equivocal HER2/neu FISH Results in Breast Cancer: How Frequently Do They Change on Repeat Testing?
    Chang, Nina
    Chen, Hui
    Al-Awadhi, Aydah M.
    Tang, Guilin
    Robinson, Melissa K.
    Lim, Bora
    Sahin, Aysegul
    LABORATORY INVESTIGATION, 2018, 98 : 53 - 53
  • [23] Equivocal HER2/neu FISH Results in Breast Cancer: How Frequently Do They Change on Repeat Testing?
    Chang, Nina
    Chen, Hui
    Al-Awadhi, Aydah M.
    Tang, Guilin
    Robinson, Melissa K.
    Lim, Bora
    Sahin, Aysegul
    MODERN PATHOLOGY, 2018, 31 : 53 - 53
  • [24] The relation between percentage of immunostained cells and amplification status in breast cancers with equivocal result for Her2 immunohistochemistry
    Onguru, Onder
    Zhang, Paul J.
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (05) : 381 - 384
  • [25] Impact of the 2013 ASCO/CAP Guideline Recommendations for HER2 Testing of Invasive Breast Carcinoma: A Focus on Tumors Assessed as Equivocal for HER2 Gene Amplification By FISH
    Bethune, Gillian
    van Zanten, Daniel Veldheijzen
    Younis, Tallal
    Rayson, Daniel
    Thompson, Kara
    Barnes, Penny
    MODERN PATHOLOGY, 2015, 28 : 35A - 35A
  • [26] HER2 status in breast cancer: immunohistochemistry and gene amplification in the Republic of Kazakhstan
    Lyubko, S.
    Satbaeva, E.
    VIRCHOWS ARCHIV, 2019, 475 : S73 - S74
  • [27] Is "Polysomy" in Breast Carcinoma the "New Equivocal" in HER2 Testing?
    Swanson, Paul E.
    Yang, Hua
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) : 181 - 184
  • [28] The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer
    Diaz, LK
    Gupta, R
    Kidwai, N
    Sneige, N
    Wiley, EL
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (04) : 501 - 507
  • [29] The role of HER2 gene copy number variations in immunohistochemistry-equivocal (2+) breast cancer
    Kocsmar, I.
    Tokes, A. M.
    Kafer, D.
    Kocsmar, E.
    Kristof, K. Attila
    Kulka, J.
    Lotz, G.
    VIRCHOWS ARCHIV, 2020, 477 : S225 - S225
  • [30] Her2 Amplification Status in Iranian Breast Cancer Patients: Comparison of Immunohistochemistry (IHC) and Fluorescence in situ Hybridisation (FISH)
    Ghaffari, Saeed Reza
    Sabokbar, Tayebeh
    Dastan, Jila
    Rafati, Maryam
    Moossavi, Shirin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 1031 - 1034
12345